July 12, 2007 - July 17, 2007
Alpa IPO Latest News Today
Track all the latest updates and news of Alpa IPO.
-
Loar: A First Deal Post The IPO
July 21, 2024 6:58:00 PM
Loar's high valuation post-IPO raised concerns, despite solid earnings and acquisition performance. Check out my recommendation for LOAR stock.
Published by : Seeking Alpha -
U.S. IPO Weekly Recap: Insurance And Healthcare Lead A 4 IPO Week
July 20, 2024 12:20:00 PM
A handful of IPOs priced this past week, led by three sizable names. One large issuer joined both the pipeline and the calendar - Chile-based LATAM Airlines Group.
Published by : Seeking Alpha
Alpa IPO Alerts
Alpa Laboratories Limited IPO listing date & Info:
Listing On: Monday, August 6, 2007
BSE Script Code: 532878
NSE Symbol: ALPA
Listing in: B1 Group of Securities in BSE
ISIN: INE385I01010
Issue Price: Rs. 68/- Per share (Face Value of Rs. 10/-)
Alpa Laboratories Limited IPO listing date & Info:
Listing On: Monday, August 6, 2007
BSE Script Code: 532878
NSE Symbol: ALPA
Listing in: B1 Group of Securities in BSE
ISIN: INE385I01010
Issue Price: Rs. 68/- Per share (Face Value of Rs. 10/-)
IPO Allotment Status is now available online for Alpa Laboratories Limited.
Alpa Laboratories Limited IPO was closed on July 17, 2007 and was oversubscribed by around 1.11 times (retail 2.14 times).
IPO Allotment Status is now available online for Alpa Laboratories Limited.
Alpa Laboratories Limited IPO was closed on July 17, 2007 and was oversubscribed by around 1.11 times (retail 2.14 times).
Alpa Laboratories Limited is in the business of manufacturing of pharmaceutical formulations. Alpa manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms. It also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands).
Alpa Laboratories Limited is entering the capital markets with an initial public offering, IPO of 95,00,000 Equity Shares, for cash, at a premium to be decided through a 100% Book Built Issue.
The price band for the issue has been fixed at Rs 62/- at lower level and Rs 68/- at upper level for equity share of Rs 10. The issue opens on July 12, 2007, and closes for subscription on July 17, 2007. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
Alpa Laboratories Limited is in the business of manufacturing of pharmaceutical formulations. Alpa manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms. It also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands).
Alpa Laboratories Limited is entering the capital markets with an initial public offering, IPO of 95,00,000 Equity Shares, for cash, at a premium to be decided through a 100% Book Built Issue.
The price band for the issue has been fixed at Rs 62/- at lower level and Rs 68/- at upper level for equity share of Rs 10. The issue opens on July 12, 2007, and closes for subscription on July 17, 2007. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
Alpa Laboratories Limited is in the business of manufacturing of pharmaceutical formulations. Alpa manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms. It also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands).
Alpa Laboratories Limited is entering the capital markets with an initial public offering, IPO of 95,00,000 Equity Shares, for cash, at a premium to be decided through a 100% Book Built Issue.
The price band for the issue has been fixed at Rs 62/- at lower level and Rs 68/- at upper level for equity share of Rs 10. The issue opens on July 12, 2007, and closes for subscription on July 17, 2007. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
Alpa IPO News & Events FAQs
The Alpa IPO is proposed to open on July 12, 2007. The IPO application ends on July 17, 2007.
Retail investors can apply in the retail or non-institutional investor category from July 12, 2007 to July 17, 2007. The Alpa IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Alpa IPO will open for subscription on July 12, 2007. The public issue will close on July 17, 2007.
Read more about Alpa IPO
Useful Articles
By Popular
Stock Brokers
30 days brokerage free trading
Free - Personal Trading Advisor
Open Account